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Implementation of blinded outcome
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Treatments trial (EverT) – lessons learned
Sarah Cockayne1, Catherine Hewitt1, Farina Hashmi2*, Kate Hicks1, Michael Concannon3, Caroline McIntosh4,
Kim Thomas5, Jill Hall6, Judith Watson1, David Torgerson1 and Ian Watt1,7
Abstract
Background: Trials using inadequate levels of blinding may report larger effect sizes than blinded studies. It has
been suggested that blinded outcome assessment in open trials may in some cases be undertaken by assessments
of photographs. The aim of this paper is to explore the effect of using different methods to assess the primary
outcome in the EVerT (Effective Verruca Treatments) trial. It also aims to give an overview of the experiences of
using digital photographs within the trial.
Methods: We undertook a secondary analysis to explore the effect of using three different methods to assess the
primary outcome in the EVerT trial: assessment of digital photographs by blinded healthcare professionals; blinded
healthcare professional assessment at the recruiting site and patient self-report. The verruca clearance rates were
calculated using the three different methods of assessment. A Cohen’s kappa measure of inter-rater agreement was
used to assess the agreement between the methods. We also investigated the experiences of healthcare
professionals using digital photographs within the trial.
Results: Digital photographs for 189 out of 240 (79 %) patients in the trial were received for outcome assessment.
Of the 189 photographs, 30 (16 %) were uninterpretable. The overall verruca clearance rates were 21 % (43/202,)
using the unblinded patient self-reported outcome, 6 % (9/159,) using blinded assessment of digital photographs
and 14 % (30/210,) using blinded outcome assessment at the site.
Conclusions: Despite differences in the clearance rates found using different methods of outcome assessment, this
did not change the original conclusion of the trial, that there is no evidence of a difference in effectiveness
between cryotherapy and salicylic acid. Future trials using digital photographs should consider individual training
needs at sites and have a backup method of assessment agreed a priori.
Trial registration: ISRCTN Registry ISRCTN18994246
Keywords: Blinding, Digital photographs, Outcome assessment, Randomised controlled trial
Background
Blinding is widely used in randomised controlled trials
to minimise the possibility of introducing bias as a result
of those involved in the study being aware of which
treatment has been received [1]. There are several po-
tential issues if patients, investigators and outcome as-
sessors are aware of the treatment allocation. First,
patients who know they have received a new treatment
may hold either favourable expectations or increased ap-
prehension, whilst those receiving the standard treat-
ment may feel deprived or relieved. Such knowledge
may affect psychological or physical responses and could
influence the patient’s cooperation in the trial for ex-
ample attendance for evaluation [2]. Second, investiga-
tors who are aware that patients are receiving a novel
intervention may follow their progress more closely than
those on standard treatment. Alternatively they may
transfer their opinion either for or against a treatment to
the patient which may affect the patient’s attitude [3].
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Finally, for outcome assessors there is the potential to
report more favourable outcomes for those in the novel
intervention group if they believe it to be a superior
treatment. However, this is more likely to be an issue
where more subjective outcomes such as pain scores are
being assessed rather than objective outcomes such as
death.
Trials which have not used appropriate levels of blind-
ing have been shown to report larger effect sizes than
blinded studies [4]. It has been suggested that blinded out-
come assessment in open trials may in some cases be
undertaken by assessment of photographs [5] and digital
photographs have been used previously in randomised
controlled trials to assess outcome [6, 7]. Digital photo-
graphs are a useful way of capturing and demonstrating
global changes in lesions as well as providing objectivity
and reproducibility. It may be possible to use computer al-
gorithms to identify the lesion and analyse its size and
shape, as well as identify any irregularity of colour and
segmentation [8]. There are several advantages to using
digital photographs for outcome assessment. First, it elim-
inates the verbal and non-verbal clues about group alloca-
tion and allows the same assessors to evaluate the
outcome for all participants in a study. Second, it assists
with demonstrating the transparency of the data. Finally,
it may assist with centrally monitoring the study, for ex-
ample confirmation of the existence of patients which
may help identify fraudulent behaviour or validate compli-
ance with the trial protocol over the number of treatment
visits. Used in conjunction with telecommunications,
digital imaging can extend the reach of patient participa-
tion in studies. However, a number of disadvantages of
using digital photographs also exist, including the pur-
chase cost of equipment, although this has reduced in re-
cent years; the time to take and process photographs; and
the need to train staff. Furthermore, additional time is re-
quired to handle the photographs at the study coordinat-
ing centre.
The EVerT (Effective Verruca Treatments) trial com-
pared the use of cryotherapy delivered by a healthcare
professional to self-administered salicylic acid. As such,
it was not possible to blind the patients or the healthcare
professionals to their treatment allocation. In order to
ensure adequate blinding outcome assessments were
undertaken in two ways. Firstly a digital photograph of
the verruca(e) was taken. As far as we are aware, this is
the first study to undertake this type of assessment in
such a trial. Second a healthcare professional at the site,
who was not involved in treating the participants,
assessed the patient to determine whether their verru-
ca(e) was/were still present. It was agreed a priori to use
the digital photos as the means of assessment, and as-
sessment at the site would only be used if this was unin-
terpretable. The aim of this paper is to undertake a
secondary analysis to explore the effect of using different
methods to assess the primary outcome in the EVerT
trial. It also aims to give an overview of the experiences
of using digital photographs in the trial in order to in-
form future dermatology trials.
Methods
The EVerT trial
The EVerT trial was a multicentre, two arm randomised
controlled open trial evaluating the clinical and cost ef-
fectiveness of salicylic acid and cryotherapy for the treat-
ment of verrucae. The study was approved by Trent
Multicentre Research Ethics Committee (MREC refer-
ence 04/mre04/59), Galway Research Ethics Committee,
local research ethics committees, Medicines and Health-
care products Regulatory Agency, Irish Medicines Board
and local Research and Development Trusts. All patients
provided written informed consent prior to being en-
rolled in the study. Detailed methods [9, 10] and the
main trial results have been published elsewhere [11]. In
brief, 240 patients were recruited from University podia-
try schools, NHS podiatry clinics and primary care. Pa-
tients were eligible for the study if they were over
12 years of age and had at least one verruca which was
suitable for treatment with both trial treatments. Pa-
tients were randomly allocated to receive cryotherapy
using liquid nitrogen or self-treatment with 50 % sali-
cylic acid. The primary outcome was complete clearance
of all verrucae at 12 weeks after randomisation as ob-
served on digital photographs by blinded podiatrists and
by blinded assessment at the recruiting site by podia-
trists, General Practitioners and Practice Nurses. Patient
self-reported clearance rates at 12 weeks were also ob-
tained via postal questionnaire.
Digital photographs and outcome assessment methods
Study sites were requested to take digital photographs at
baseline and at the 12 week outcome assessment visit.
The photographs were taken using either a Nikon Cool-
pix L11 digital camera provided by the trial, or the
Healthcare Professional’s (HCP’s) own camera if it was a
similar specification. Sites were given written guidelines
on how to use the camera. Digital photographs received
by the coordinating centre were reviewed and further
advice given by telephone in cases where the quality of
the photographs received would make it difficult to in-
terpret. The photographs were assessed by two assessors
who were blind to treatment allocation. They independ-
ently assessed the photographs for each participant to
determine whether the verrucae had cleared. Any dis-
crepancies were referred to a third assessor. The asses-
sors were asked to record if the photograph was
uninterpretable and the reasons why and record if they
knew for certain which treatment the patient received.
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Patient self-reported clearance rates at 12 weeks were
also obtained via postal questionnaire. Participants who
did not attend their 12 week outcome assessment visit
were asked to take a digital photograph of their foot and
email it to the coordinating centre.
Statistical analysis
The number of uninterpretable photographs by centre
were summarised descriptively. The available outcome
assessment data were summarised descriptively along
with the baseline data and effectiveness of the blinding.
The verruca clearance rates were reported using the
three different methods of assessment and a Cohen’s
kappa measure of inter-rater agreement was used to as-
sess the agreement between the methods of assessment.
We fitted a logistic regression model with verruca clear-
ance (yes/no) as the primary outcome and treatment,
age, type of verruca and previous treatment as covari-
ates. Three analyses were undertaken, one using the
digital photograph reported outcome at 12 weeks, one
using the blinded outcome assessment at the site at
12 weeks and one using patient’s self-reported outcome
at 12 weeks. The results of these analyses were then re-
ported graphically.
All analyses were conducted on an intention-to-treat
basis, including all patients in the groups to which they
were randomised. All analyses were conducted using
Stata version 13.0 (Texas, USA) using two sided signifi-
cance tests at the 5 % significance level.
Results
Secondary analysis to explore the effect of using different
methods of outcome assessment
Figure 1 shows the flow of patients through the trial. In
total 240 eligible patients were recruited to the study.
Digital photographs were taken at the 12 week outcome
assessment point and the coordinating centre received
photographs for 189/240 (79 %) patients. The coordinat-
ing centre did not successfully receive photographs for
51 patients and the reasons for the missing data were as
Fig. 1 Flow of patients through the trial
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follows: patient did not attend their outcome assessment
and so no photograph was taken (n = 31); photographs
were missing (n = 17); unclear photographs not given to
the assessor (n = 2); and not possible to identify which
patient the photograph related to (n = 1). The number of
uninterpretable photographs by centre and type of
healthcare professional is documented in Table 1. Of the
189 photographs given to the blinded assessors, 30
(16 %) were deemed by the assessors to be of insufficient
quality to allow an assessment to be undertaken
(Table 1). In the majority of these cases (n = 27) the
photograph could not be interpreted because it was not
in focus. The digital photograph assessors reported 16
cases where they were aware of the treatment the patient
received. In all cases they reported that the patient had
received treatment with salicylic acid, an assumption
which on review of the participant’s group allocation
was found to be correct in 14 of the 16 cases. For 210 of
the 240 (88 %) patients in the study had blinded out-
come assessments at the site. Patient self-reported clear-
ance of verrucae via the 12-week postal questionnaire
was available for 202/240 (84 %) patients. A summary of
the available outcome assessment data for patients in
the study is presented in Table 2.
Table 3 presents the descriptive statistics for the base-
line characteristics of patients and their presenting ver-
rucae between the three types of outcome assessment.
In general the groups were balanced at baseline. The
clearance rates of verrucae by assessment method are re-
ported in Table 4. The Cohen’s kappa measure of agree-
ment between the three methods of assessment was
estimated as 0.61 (p < 0.001). This indicates a good level
of agreement between the three methods. Results of the
logistic regression model of verruca gone status were as
follows: assessment by photograph OR 1.93 (95 % CI
0.46 to 8.13) p = 0.371: blinded assessment at site: OR
0.80 (95 % CI 0.35 to 1.81) p = 0.593 and patient self-
report OR 0.81 (0.40 to 1.64) p = 0.553. None of the as-
sessment methods resulted in a statistical significant re-
sult. These results are reported graphically in Fig. 2.
The overall verruca clearance rate reported using the
patient self-reported outcome data was higher than the
rates using both blinded digital photograph assessment
and blinded healthcare professional assessment at the
site. Although there was little or no evidence of differ-
ence in clearance rates using any of the methods of as-
sessment, there was a change in the direction of the
effect for the blinded digital photograph assessment
compared to the other forms of assessment. Assessment
using digital photographs reported slightly higher cure
rates with salicylic acid compared to cryotherapy and
blinded outcome assessment at the site and patient self-
reported outcomes reported higher cure rates with cryo-
therapy compared to salicylic acid.
Our experiences of using digital photographs
All the patients in this study consented to have photo-
graphs taken. Healthcare professionals who either took
photographs as part of their routine clinical practice or
had an interest in photography had few difficulties with
taking and processing the photographs. However, other
Table 1 Number of uninterpretable photographs by centre and
type of healthcare professional
Centre ID
number
Type of
healthcare
professional
Number of
photographs
Number of
uninterpretable
photographsa
Take digital
photos as
part of their
routine work
1 Podiatristb 48 0 Yes
2 GP 1 0 No
3 Practice nurse 4 2 No
4 Podiatrist 9 1 Yes
5 Podiatristb 33 4 Yes
6 GP 12 0 No
7 Podiatrist 11 0 Yes
8 Practice nurse 5 1 No
9 Podiatrist 8 2 No
10 Podiatrist 33 16 No
11 Practice nurse 13 4 No
12 Practice nurse 3 0 No
13 GP 9 0 No
Total 189 30
a Photograph uninterpretable due to being unclear (n = 27); insufficient detail
(n = 4); lesion obstructed by identifier card (n = 1); other reason (n = 1). More
than one category could be checked so the total for all categories totals more
than 30
b HCP used their own camera; all other sites used the camera provided by
the trial
Table 2 Summary of available outcome assessment data
Data available Number of patients
N = 240
Photograph, blinded assessment at
site and patient self-report
142
Blinded assessment at site and patient
self-report (no photograph)
41
Photograph and blinded assessment at
site (no patient self-report)
17
Photograph and patient self-report
(no blinded assessment at site)
0
Only had photograph (no blinded
assessment at site and no patient self-report)
0
Only had blinded assessment at site
(no photograph and no patient self-report)
10
Only had patient self-report (no photograph
and no blinded assessment at site)
19
Missing data (no photograph, no blinded
assessment at site or patient self-report)
11
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HCPs found the process challenging, time consuming
and often took out of focus photos. This was despite
attempts to improve their quality e.g. by reviewing
photos at the site whilst the patient was still present
and taking multiple photographs. One site which did
not routinely take photos as part of their routine
work, experienced such difficulties in taking photo-
graphs with the camera provided to them by the trial,
that they requested assistance from the trust’s medical
photographer. Whilst they were willing to take the
photographs, this was not practically possible due to
their considerable distance from the podiatry depart-
ment. In 13 cases where patients did not attend their
outcome assessment, the coordinating centre wrote to
them asking if they would send a digital photograph.
One patient complied with this request.
Anecdotally, assessors reviewing the digital photo-
graphs reported several reasons why they were unable
to interpret them. In some cases the photograph was
taken too far away to allow close inspection. However,
if the zoom facility was used it sometimes resulted in
the image being blurred or distorted. Problems with
lighting resulting in glare or shadows also made as-
sessment difficult. Reviewers found it helpful to have
more than one concurrent photograph as it either in-
creased the chances of obtaining a better quality
photograph or helped in cases where the lesion ex-
tended around the foot or where both feet were af-
fected. However, if the baseline photograph was
unclear, assessing the follow up photograph for any
change was problematic. Assessors found it frustrating
not to be able to review the patient in person, as they
said it would have helped in their assessment. Al-
though not only an issue for assessment using digital
photographs, in some cases it was possible to see that
the patient had been treated with salicylic acid due to
the circular shaped macerated area surrounding the
verrucae, which resulted from treating with the sali-
cylic acid.
Table 3 Baseline characteristics of participants according to
type of outcome assessment
Photograph Blinded assessment
at site
Patient
self-report
(N = 159) (N = 210) (N = 202)
Age (years)
N, Mean (SD) 158, 30.8
(16.6)
209, 30.7
(16.4)
200, 30.9
(16.7)
Median (min, max) 24.5
(12.0, 75.3)
24.2
(12.0, 75.3)
24.3
(12.0, 75.3)
Missing 1 1 2
Gender
Female (%) 109 (69.0) 140 (67.0) 136 (68.0)
Male (%) 49 (31.0) 69 (33.0) 64 (32.0)
Missing 1 1 2
Type of verrucae
Mosaic, n (%) 36 (23.4) 42 (20.6) 46 (23.4)
Non-mosaic, n (%) 118 (76.6) 162 (79.4) 151 (76.7)
Missing 4 6 5
Duration of verrucae
(months)
N, Mean (SD) 149, 29.5
(26.7)
199, 26.9
(25.2)
192, 26.9
(25.5)
Median (min, max) 24
(1, 144)
18
(1, 144)
19.1
(1, 144)
Missing 10 11 10
Number of verrucae
at baseline
N, Mean (SD) 152, 4.0
(5.9)
201, 3.8
(5.5)
194, 3.9
(5.5)
Median (min, max) 2 (1, 55) 2 (1, 55) 2 (1, 55)
Missing 7 9 8
Previous treatment
Yes, n (%) 130 (82.3) 163 (78.0) 161 (80.5)
No, n (%) 28 (17.7) 46 (22.0) 39 (19.5)
Missing 1 1 2
Type of previous
treatmenta
Self-treatment, n (%) 113 (86.9) 144 (88.3) 141 (87.6)
Podiatrist/chiropodist,
n (%)
41 (31.5) 47 (28.8) 43 (26.7)
GP, n (%) 56 (43.1) 65 (40.0) 64 (39.8)
Trial investigating
verruca treatments, n (%)
2 (1.5) 2 (1.2) 2 (1.2)
Other, n (%) 12 (9.2) 14 (8.6) 14 (8.7)
a More than one category could be checked so the total for all categories may
total more than 100 %
Table 4 Verruca clearance rates by assessment method
Clearance Cryotherapy
Number (%)
Salicylic acid
Number (%)
Total
Number (%)
Digital photograph
Gone 3 (3.8) 6 (7.6) 9 (5.7)
Not gone 77 (96.2) 73 (92.4) 150 (94.3)
Total 80 (100.0) 79 (100.0) 159 (100.0)
Blinded assessment at site
Gone 17 (16.5) 13 (12.2) 30 (14.3)
Not gone 86 (83.5) 94 (87.9) 180 (85.7)
Total 103 (100.0) 107 (100.0) 210 (100.0)
Patient self-report
Gone 21 (21.9) 22 (20.8) 43 (21.3)
Not gone 75 (78.1) 84 (79.2) 159 (78.7)
Total 96 (100.0) 106 (100.0) 202 (100.0)
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Other trials managed by the York Trials Unit have re-
ported additional issues with handling digital photo-
graphs. Although it was not an issue in this study, some
NHS Trusts only allow medical imaging staff to take
photographs of patients. Whilst this improves the quality
of the photographs received, it increases costs and the
amount of time spent at the clinic for patients. Other
NHS Trusts do not allow non-NHS software to be
uploaded onto their computers. This resulted in memory
cards having to be sent back to the coordinating site.
Discussion
This study has demonstrated that it is possible to use
digital photographs to assess verruca clearance rates.
However some potential problems are highlighted that re-
searchers should be aware of. There was a variation be-
tween sites as to the quality of the photographs taken and
so individualised training needs should be assessed. It also
highlights the need to have a back-up option in place in
case the image fails. Using a combination of outcome as-
sessment methods allowed us to minimise the amount of
missing data in this study. However, the type and priority
of data to be used for analysis should be agreed a priori.
As we anticipated the verruca clearance rates were
highest when they were self-reported by participants.
This could be due partly to the fact that the patients
were unblinded to the treatment they received. Some pa-
tients allocated to cryotherapy may have reported higher
cure rates because they believed the treatment must
have been effective as the treatment was painful. Simi-
larly the podiatrists undertaking the blinded outcome as-
sessment both at site and on the photos may have over
or under reported clearance rates in those cases where
they were able to correctly identify the patient had been
treated with salicylic acid. Alternatively it could be due
to the healthcare professionals using different criteria on
which to define clearance. Healthcare professionals were
asked to review whether there was “restoration of nor-
mal skin upon close inspection”, whilst patients were
asked if their verruca(e) had gone or not and were not
given any criteria on which to make this judgement. It
may have been possible that patients, who reported their
verruca as being unsightly and/or painful, may have used
these criteria on which to base whether or not their ver-
ruca had been cured, if these signs and symptoms were
reduced after treatment. It has been suggested that pa-
tients may be able to detect changes in their lesions if
they are given the opportunity to review the original le-
sion on a photograph [12]. The overall cure rate re-
ported by patients may therefore have been lower if this
type of assessment had been undertaken. Whilst the
clearance rates as assessed by digital photograph or as-
sessment at the site varied considerably this is most
likely due to the small numbers involved with the low
cure rate. In this case the largest effect size was not seen
in the unblinded assessment but in the blinded assess-
ment at the site. Whilst there was a change in the direc-
tion of effect when using digital photographs compared
to assessment at the site or patient self-reported out-
comes, none of the assessment methods resulted in a
statistically significant result. The conclusion of the
study therefore did not change with the type of assess-
ment used, i.e. there was no evidence of a difference in
effectiveness between the treatments. However care
should be taken in interpreting these results due to the
very low overall cure rates.
0.80 (0.35 to 1.81)
0.81 (0.40 to 1.64)
1.93 (0.46 to 8.13)
Blinded assessment at site
Digital photo
Self report
-6 -4 -2 0 2 4 6 8 10
Favours Cryotherapy     Favours Salicyclic acid
Fig. 2 Forest plot of assessment method comparing salicylic acid and cryotherapy for treatment of verrucae
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Manual tracking of digital photographs by the trial co-
ordinating centre was a time consuming process. How-
ever, there are now automated systems, whereby
photographs are uploaded directly which would overcome
this problem. Whilst it might have been possible to obtain
higher quality pictures if using a higher specification of
camera there are of course cost and training implications.
Whilst technology has improved the potential for taking
poor quality photos still remains a possibility. In this study
staff often took multiple photos. Whilst these photos were
reviewed at the point of taking them, some sites reported
that the photograph looked in focus on the LCD screen
but when uploaded onto the computer was then found to
be out of focus. In future trials, attention needs to be paid
to digital image reliability, reproducibility, security and
usefulness to ensure issues surrounding authentication,
manipulation, audit trail verification and data compression
are considered [13].
Conclusions
In conclusion, although there was a difference in the dir-
ection of the effect for verruca clearance rates using data
from blinded digital photographs, blinded assessment at
the site and unblinded patient self-report, none of the re-
sults reached statistical significance. The original conclu-
sion drawn from the study i.e. that there is no evidence of
a difference in effectiveness between cryotherapy using li-
quid nitrogen and daily self-treatment with 50 % salicylic
acid is not changed. In future trials we would recommend
that if digital photographs are to be used as a means of
outcome assessment, then training needs at individual
sites should be assessed and more than one photograph
should be taken at each time point and an automated
process of handling photographs should be used. We
would suggest having a backup method of assessment but
it should be agreed a priori which data should be used.
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